-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that on October 9, Xiansheng Pharmaceutical (02096.HK) announced that it would spend HK$17.369.89 million to buy back 1.598 million shares. This is the company's fifth share repurchase since September. Such frequent and vigorous repurchase operations have sent a clear valuation signal: the company has firm confidence in its intrinsic value and medium- to long-term development prospects.

Zhitongcaijing·10/09/2026 13:33:13
Listen to the news
The Zhitong Finance App learned that on October 9, Xiansheng Pharmaceutical (02096.HK) announced that it would spend HK$17.369.89 million to buy back 1.598 million shares. This is the company's fifth share repurchase since September. Such frequent and vigorous repurchase operations have sent a clear valuation signal: the company has firm confidence in its intrinsic value and medium- to long-term development prospects.